FDA 483 - MedImmune U.K. Limited

An FDA inspection of MedImmune UK Limited, a vaccine manufacturer in Speke, Liverpool, revealed significant deficiencies across six observations. Issues included inadequate controls for manufacturing materials, delayed corrective and preventive actions, and poor sterility testing practices. The firm also lacked proper procedures for alarm trending, water system quarantine, and deviation documentation.